Chemi-Verse™ PAK7 Kinase Assay Kit

Catalog #
82183
$535 *
Size: 96 reactions
Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

The Chemi-Verse™ PAK7 Kinase Assay Kit is designed to measure PAK7 (p21-activated kinase 7) serine/threonine kinase activity for screening and profiling applications using ADP-Glo™ as a detection reagent. The assay kit comes in a convenient 96-well format, with enough purified recombinant PAK7 kinase, kinase substrate, ATP, and kinase assay buffer for 100 enzyme reactions.

Synonyms
PAK5; KIAA1264; MGC26232
Product Info
Storage and Usage
Citations
Assay Kit Format
Luminescent
Materials Required But Not Supplied
  • ADP-Glo™ Kinase Assay (Promega #V6930)
  • DTT (Dithiothreitol), 1M, optional
  • Microplate reader capable of reading luminescence
  • Adjustable micropipettor and sterile tips
  • 30°C incubator
Format
Catalog # Name Amount Storage
  PAK7* 1 µg -80°C
79334 5x Kinase Buffer 1 1.5 ml -20°C
79686 500 µM ATP 50 µl -20°C
  PAKtide, 1 mg/ml 500 µl -20°C
79696 White 96-well plate 1 Room Temp

*The concentration of the protein is lot-specific and will be indicated on the tube.

UniProt #
Q9P286
Background

PAK7 (p-12-activated kinase 7), also known as PAK5, is a member of the PAK family of serine/threonine kinases. The PAK family is highly evolutionary conserved and regulates cell survival, apoptosis, cytoskeleton dynamics, and other critical cellular functions. PAK7 belongs to group II, which can be activated by Cdc42 (cell division control protein 42) only, as opposed to group I, which depends on either Rac1 or Cdc42.I It is found mostly in the brain, where it participates in neurite outgrowth and microtubule stabilization. Deletion of PAK7 in mice results in defects in memory, learning and movement. PAK7 is regulated by Aurora kinase A, both being upregulated in esophageal squamous carcinoma. In turn, PAK7 phosphorylates proteins like synaptojanin-1, pacsin-1, GATA1 and p120-catenin. PAK7 has also been identified as a risk factor for psychosis, which may result from abnormal synapse development and plasticity. Upregulation of PAK7 has been found in several cancer types, such as gastric, breast, ovarian cancer, osteosarcoma and others, where it also contributes to cell survival and resistance to chemotherapy. The development of specific inhibitors targeting PAK7, to be used alone or in combination therapy, will greatly benefit the cancer therapy field.

References

Wu A. and Jiang J., 2022 Leukemia 36:315-326.
Morris D., et al., 2014 Hum Mol Genet 23(12):3316-3326.
Gu Y.-F. and Kong L.T., 2021 Human & Experimental Toxicology 40(12): 2202-2214.